Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DDM Holding AG and DDM Debt AB to report first quarter 2021

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM2) will publish their Q1 2021 reports on Thursday 6 May 2021 at 08:00 CEST. Mr. Henrik Wennerholm, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CEST, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Sweden: +46 8 505 583 51Switzerland: +41 225 805 976 or

DDM Holding AG and DDM Debt AB to report first quarter 2021

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM2) will publish their Q1 2021 reports on Thursday 6 May 2021 at 08:00 CEST. Mr. Henrik Wennerholm, CEO, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CEST, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or by telephone with dial-in numbers: Sweden: +46 8 505 583 51Switzerland: +41 225 805 976 or

DanCann Pharma A/S has pressed the start button in BIOTECH PHARM1

COPENHAGEN, Denmark, 22 April 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announce that following pre-selective operations around the Company's genetics in BIOTECH PHARM1 (“the Facility”), the Company today begins its first real operations and first cycles in its new Facility.The Danish biopharmaceutical manufacturer DanCann Pharma has just announced that the first phase in the establishment of the company's high-tech production Facility, the BIOTECH PHARM1, in Ansager has now been completed - and that the Facility has been put into operation. The

Wood becomes more popular in the construction of apartment buildings – the majority of the environmental impact of buildings is created during use

YIT CORPORATION News, April 22, 2021 at 09:00 a.m.The construction industry needs to reduce its environmental impact, and public investments in the promotion of wood construction are part of this development. YIT is constantly improving its competence in wood construction. The environmental impact of material selections requires additional investigations, but it is already clear that climate action should also be directed at reducing life cycle emissions. Wood construction is becoming increasingly popular, and policies concentrating on addressing climate change, both at governmental and

Interim report for Q1 2021

Continued high activity in the first quarter – infection prevention a global sustainability issueFirst quarter (January-March 2021) · Revenues amounted to SEK 41.8 (48.1) million, a decrease by 13%. Adjusted for currencies the decrease was 3%. · EBITDA amounted to SEK 1.9 (14.4) million with an EBITDA-margin of 5% (30%). · Operating profit amounted to SEK -9.7 (3.9) million. · Net loss for the period amounted to SEK -10.5 (-11.2) million. Earnings per share amounted to SEK -0.31 (-0.34). · Cash flow from operating activities amounted to SEK -0.9 (-3.5) million corresponding

Loudspring Oyj: Q1 2021 Summary

Loudspring Oyj Company release 22nd April 2021 at 9:00 (EEST) Please note that this report is not a fully comprehensive report of all events, nor is it in any way a financial performance report. It is only a summary of the main events that have affected us and our portfolio during the quarter and before the date of this report where separately indicated below. In the quarterly report we will not comment on every portfolio company but focus on our core holdings. To get a comprehensive overview of individual portfolio companies’ businesses one should review additional documents

Neste to publish its first quarter results on 29 April 2021

Neste Corporation, Press Release, 22 April 2021 at 9 a.m. (EET)Neste will publish its first quarter 2021 results on Thursday, 29 April 2021 at approximately 9 a.m. (EET). The release will be available on the Neste website  immediately after publishing.A conference call in English for investors and analysts will be held on 29 April 2021, at 3 p.m. Finland / 1 p.m. London / 8 a.m. New York. The call-in numbers are as follows: Finland: +358 (0) 9 2311 3291, rest of Europe: +44 (0) 20 7192 8338, US: +1 646 741 3167, using access code

Metso Outotec launches robust camera solution for smelting furnaces to increase safety and availability

Metso Outotec Corporation’s press release on April 22, 2021, at 09:00 a.m. EESTMetso Outotec is launching a robust Furnace Camera to reduce or even eliminate the need to power off or cut the feed to inspect the furnace. Operators can safely monitor conditions inside the furnace in real time and react immediately to situations that would otherwise not necessarily be detected. The furnace camera is a fully integrated solution that is fast and easy to install into new or existing furnaces.  “The Metso Outotec Furnace Camera is part of our extensive range of smart digital tools designed to

Interim Report, January – March 2021

Good sales growth and strategic acquistion in SwedenJanuary - March 2021 · Revenues increased by 6 percent to SEK 894 (844) million. · Adjusted EBITA decreased by 2 percent and amounted to SEK 41.6 (42.6) million, corresponding to an adjusted EBITA margin of 4.7 (5.1) percent. · Profit before tax amounted to SEK 30.8 (33.4) million. · Profit after tax amounted to SEK 22.5 (25.8) million. · Profit per share amounted to SEK 2.47 (2.85). · New contracts relating to cloud services worth SEK 78 (51) million were contracted, an increase by 53 percent. · Proact topped the

NENT Group’s first Estonian Viaplay Original is ‘Who Shot Otto Mueller?’

· Jaan Rekkor, Tambet Tuisk and Märt Avandi lead all-star Estonian cast · Crime drama is directed by René Vilbre and scripted by Birk Rohelend · ‘Who Shot Otto Mueller?’ will premiere exclusively on Viaplay An unprecedented line-up of Estonia’s top creative talents will partner with Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, to create the first-ever Estonian Viaplay Original. Helmed by award-winning director René Vilbre and written by Birk Rohelend, the tense crime drama ‘Who Shot Otto Mueller?’ stars Jaan Rekkor, Tambet Tuisk and Märt

Rottneros interim report January-March

Rising prices and strong demand for market pulp· SOLD VOLUME was 112,0 (110,0) thousand tonnes due to strong demand for market pulp.  · PRODUCED VOLUME was 102,5 (109,4) thousand tonnes. It was mainly the cold winter that had a negative impact on production.  · THE CORONA PANDEMIC entails continued measures to minimise the risk of spreading the infection in the Group’s facilities. Production was not affected by the pandemic during the quarter. However, the development at Packaging has been delayed.  · NET TURNOVER decreased by 7 percent to 542 (585) MSEK. The higher list

Alimak Group: Interim report January – March 2021

Margin improvements · Currency translation effects had negative impact on reported order intake, revenue and earnings · Organic order intake growth of 7% · Revenue flat organically as expected due to incoming order backlog and continued effects of the COVID-19 pandemic · Margin improvements in all divisions and cost savings programme on track · Strong Cash Flow and further strengthened financial position First quarter · Order intake increased by 1% to MSEK 1,073 (1,067) with an organic increase of 7% · Revenue decreased by 8% to MSEK 846 (916) with an organic

Hansa Biopharma interim report Jan-Mar 2021

First commercial sales of Idefirix[®] recorded in Q1; New preclinical collaboration with argenx; Encouraging three-year follow-up data in kidney transplantationLund, Sweden April 22, 2021 Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and interim report for January – March, 2021. Highlights for the first quarter 2021 · First commercial sales of  Idefirix[®] recorded in Q1 2021 following treatment of the first patients. Commercial launch activities in early launch countries continue to be carried

Interim report January–March 2021: Recovery and good profitability

First quarter: · Sales amounted to SEK 379 (334) million, corresponding to an increase of 14 percent in SEK. Sales increased by 20 percent in local currency. · Operating income before depreciation and amortisation (EBITDA) amounted to SEK 163 (116) million, corresponding to a margin of 43 (35) percent. Fluctuations in exchange rates negatively impacted EBITDA by SEK 10 million. · Net income amounted to SEK 119 (80) million, which gave earnings per share of SEK 1.09 (0.74). Gothenburg, April 22, 2021VITROLIFE AB (publ)Thomas Axelsson, CEO

Interim Report January-March 2021

First quarter · Order intake amounted to SEK 1,027 (1,432) million, a decline of 28 percent · Net sales increased 75 percent to SEK 1,291 (736) million. Based on constant exchange rates the increase was 88 percent · EBIT increased to SEK 498 (55) million and EBIT margin was 39 (8) percent  · Earnings per share were SEK 3.99 (0.40) “We delivered a stable start to the year. We continue to focus on helping our customers address the challenges still being created by the pandemic. We delivered growth of 75 percent and the EBIT margin improved to 39 percent, which was largely

Robin Boheman new CEO of Instalco

Robin Boheman, CFO of Instalco, has been appointed new CEO of the company. Robin will assume the position on 1 September 2021.Robin Boheman was one of the first employees in Instalco after CEO Per Sjöstrand and has been part of the Group management team since the start. Robin worked as Head of M&A and Business Development between 2014-19 and was appointed as CFO of the group in 2019. He has prior experience of strategy development in listed companies and he has also worked as a consultant. He holds a MSc in accounting and finance from Uppsala University. ”Ever since he was employed,

Interim report January-March 2021

A positive start to the yearQuarter 1, 2021 · Incoming orders amounted to SEK 1,035m (995), equivalent to a currency-neutral growth of 14.7 percent compared with the same period last year. Compared with the final quarter 2020, incoming orders increased by 12.7 percent. · Net sales amounted to SEK 868m (981), equivalent to a currency-neutral decrease of of 2.7 percent compared with the same period last year. · Operating profit was SEK 87.2m (64.2), giving an operating margin of 10.0 percent (6.5). · Adjusted operating profit was SEK 87.4m (65.1), giving an adjusted operating

Progress in establishing reference centers within digital pathology

STOCKHOLM – April 22, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its first quarter results for 2021. The quarter saw strong and promising progress within digital pathology and the company’s first product, INIFY Prostate Screening. While the ongoing pandemic slowed sales slightly, solid financials – paired with close dialogues with present and prospective clients – provide a positive outlook. “Dr. Filippo Fraggetta – one of the leading pathologists in Europe

Aveny Ögonklinik expands on Gothenburg’s most fashionable street

Aveny Ögonklinik is growing by 540 square metres at Kungsportsavenyen 33. Previous retail space on the second floor is now being reconstructed to become office space and a reception for the expanding eye clinic.“We have increasing demand from our patients and at the same time a new and more comprehensive agreement with the Västra Götaland Regional Council, so it feels fantastic to be able to expand our floor space after the reconstruction. Creating the best patient experience is something that we give high priority to – excellent premises, accessibility and a really good location are worth

Wärtsilä to start the repurchase of its own shares

Wärtsilä Corporation, stock exchange release, 22 April 2021 at 08:45 AM EESTWärtsilä to start the repurchase of its own shares  The Board of Directors of Wärtsilä Corporation has decided to use the authorisation given by the Annual General Meeting held on 4 March 2021 to repurchase the company’s own shares. The maximum number of shares to be repurchased in one or more instalments is 1,700,000 shares, corresponding to approximately 0.29% of the total number of the company’s shares, which is 591,723,390. The shares will be repurchased using the company’s unrestricted equity. The shares

Interim Report for Duni AB (publ) January 1–March 31, 2021

Continued strong impact from restrictions, preparations for easingJanuary 1–March 31 · Net sales amounted to SEK 932 m (1,249), corresponding to an 25.4% decrease in sales. Adjusted for exchange rate movements, net sales decreased by 22.9%. · Earnings per share after dilution amounted to SEK -1.11 (0.43). · The performance of both sales and income for Q1 are directly related to the social restrictions. · The Duni business area is well prepared to meet the increase in demand expected as social restrictions are eased. · Operating income for the BioPak business area nearly

Gränges upgrades 2025 sustainability targets

Sustainability is a strong driver and enabler of Gränges’ long-term competitiveness and value creation. In March 2019, Gränges launched sustainability targets to 2025 and since then good progress has been achieved towards many of these. To reflect the stronger than anticipated development in the sustainability performance as well as to meet the increased interest and expectations from customers and other stakeholders, Gränges is now upgrading selected sustainability targets. The targets demonstrate Gränges’ efforts to further integrate sustainability across the company and the value chain,

EQT AB (publ) Q1 announcement 2021

CEO COMMENT – FIRST QUARTER 2021It was a busy first quarter - EQT teamed up with Exeter, creating a leader in thematic value-add  real estate investments, fundraising for EQT IX wasmaterially concluded, EQT Infrastructure V had its first close and we set the target size for the EQT Growth fund. In addition, preparations continued for EQT’s potential new strategies and initiatives. Christian Sinding,CEO and Managing Partner  HIGHLIGHTS DURING THE FIRST QUARTER 2021 · EQT signed an agreement to acquire Exeter Property Group and the combination was completed, as announced

There are no items matching the current filter
There are no more items matching the current filter
Back to top